TrialBMJ open2014

Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.

Ingolf Griebsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.